市場概況

The Immunoglobulins Market is projected to reach USD 24.29 10億まで 2029, with a 6.3% CAGR from 2023 に 2029. Immunoglobulins are glycoprotein molecules produced by plasma cells in response to antigens. The pandemic has impacted the plasma derivatives industry, increasing costs despite lower volumes collected. しかし, advancements in immunoglobulin products for rare and autoimmune diseases have fueled market growth. Technological developments in plasma fractionation and partnerships with plasma collection agencies are driving the market.

レポートは市場規模と成長をカバーしています, セグメンテーション, 競争環境, trends and strategies for global immunoglobulins market. 利害関係者が現在の市場機会を活用できるように、市場の定量的な分析を提供します。. このレポートはまた、市場動向と主要な競合他社のアプローチに基づいて、機会と戦略の上位セグメントを特定します。.

市場セグメンテーション

市場はさまざまな要因に基づいて分割されます, including product, 応用, エンドユーザー, そして地理.
製品: intramuscular immunoglobulin (IMIg), intravenous immunoglobulin (IVIg), subcutaneous immunoglobulin (SCIg)
応用: primary immunodeficiency, chronic immune deficiency polyradiculoneuropathy, secondary immunodeficiency, immune thrombocytopenic purpura, myasthenia gravis, その他
エンドユーザー: 病院と診療所, ホームケア

地理によるセグメンテーション
North America – US, カナダ
Europe – Germany, フランス, イギリス, イタリア, スペイン
アジア太平洋 – 中国, 日本, インド, 韓国, オーストラリア
Latin America – Brazil, メキシコ, アルゼンチン
中東 & Africa – South Africa, サウジアラビア, 七面鳥

IVIg is commonly used in the management of autoimmune diseases and immunodeficiency. It involves administering immunoglobulins intravenously for maximum bioavailability and efficacy. Primary immunodeficiency is the leading segment, accounting for 26.3% of the global immunoglobulins market in 2022. Symptoms of primary immunodeficiencies include recurring infections, 炎症, and low platelet count. Hospitals and clinics are the largest end-users in the market, but home care is expected to grow rapidly due to the rising demand for home healthcare services.

North America accounted for 46.4% of the global immunoglobulins market in 2022, supported by factors such as increased personal health awareness, patient-centric healthcare, advanced infrastructure, a robust plasma collection network, and prominent global vendors. Europe is the second-largest market, driven by high demand and a well-regulated market with a focus on safe blood and plasma collection. The Asia-Pacific (アジア太平洋) region is an emerging market, particularly for autoimmune disorder treatments. China leads the APAC market due to its population’s high awareness of blood donation and its importance in manufacturing life-saving products.

競争環境

The industry is dominated by CSL Limited, Takeda Pharmaceutical Company Limited, and Grifols S.A. These vendors face intense competition and strive to gain an advantage through new product introductions and regulatory approvals. Emerging markets and low-resource countries offer opportunities for new entrants due to larger populations and willingness to donate blood or plasma. Plasma procurement is crucial for vendors, leading to the establishment of extensive collection networks. Partnerships with official plasma collection agencies have driven growth for many vendors. Key companies profiled include ADMA Biologics Inc., Bharat Serums And Vaccines Limited (BSV), Biotest AG, China Biologic Products, 株式会社. (Shandong Taibang Biological Products Co., 株式会社), CSL Limited, Grifols, SA, ジョンソン & ジョンソン, Kedrion Biopharma Inc. (Kedrion SpA), LFB S.A., Octapharma AG, Reliance Life Sciences Pvt. 株式会社, Shanghai RAAS Blood Products Co., 株式会社, Takeda Pharmaceutical Company Limited, and Zydus Lifesciences Limited.

報告書の範囲

To analyze and forecast the market size of the global immunoglobulins market.
To classify and forecast the global immunoglobulins market based on product, 応用, エンドユーザー, 地理.
To identify drivers and challenges for the global immunoglobulins market.
合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global immunoglobulins market.
To identify and analyze the profile of leading players operating in the global immunoglobulins market.

このレポートを選択する理由

Gain a reliable outlook of the global immunoglobulins market forecasts from 2023 に 2029 シナリオ全体にわたって.
投資対象となる成長セグメントを特定する.
会社概要と市場データを通じて競合他社に先んじる.
Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
3ヶ月間の戦略コンサルティングとリサーチサポート.
シングルユーザーライセンスに提供される印刷認証.